Suppression of SIN3A by MiR-183 Promotes Breast Cancer Metastasis

Overview

Journal Mol Cancer Res

Specialty Cell Biology

Date 2022 Mar 5

PMID 35247910

Authors

Mackenzie L Davenport

Mara R Davis

Baylea N Davenport

David K Crossman

Aaron Hall

Jason Pike

Shuko Harada

Douglas R Hurst

Mick D Edmonds

Affiliations

Soon will be listed here.

Abstract

Implications: SIN3A expression is decreased in metastatic breast cancer in part due to miR-183.

Citing Articles

The impact of ferroptosis and ferroptosis-related non-coding RNAs on breast cancer progression.

Liu W, Jiang C, Ma Y, Wang W, Peng J, Ma W Front Cell Dev Biol. 2025; 12:1506492.

PMID: 39763590 PMC: 11701165. DOI: 10.3389/fcell.2024.1506492.

Sodium Butyrate Inhibits the Malignant Proliferation of Colon Cancer Cells via the miR-183/DNAJB4 Axis.

Pan D, Hao J, Wu T, Shen T, Yu K, Li Q Biochem Genet. 2024; 62(5):4174-4190.

PMID: 38244156 DOI: 10.1007/s10528-023-10599-z.

SAP30 promotes breast tumor progression by bridging the transcriptional corepressor SIN3 complex and MLL1.

Bao L, Kumar A, Zhu M, Peng Y, Xing C, Wang J J Clin Invest. 2023; 133(17).

PMID: 37655663 PMC: 10471174. DOI: 10.1172/JCI168362.

LINC01234 Accelerates the Progression of Breast Cancer via the miR-525-5p/Cold Shock Domain-Containing E1 Axis.

Yu J, Zhang X, He R, Yang X, Hu J, Tan F Dis Markers. 2022; 2022:6899777.

PMID: 35923244 PMC: 9343190. DOI: 10.1155/2022/6899777.

References

Cowley S, Iritani B, Mendrysa S, Xu T, Cheng P, Yada J . The mSin3A chromatin-modifying complex is essential for embryogenesis and T-cell development. Mol Cell Biol. 2005; 25(16):6990-7004. PMC: 1190252. DOI: 10.1128/MCB.25.16.6990-7004.2005. View

Shang C, Hong Y, Guo Y, Liu Y, Xue Y . MiR-210 up-regulation inhibits proliferation and induces apoptosis in glioma cells by targeting SIN3A. Med Sci Monit. 2014; 20:2571-7. PMC: 4266365. DOI: 10.12659/MSM.892994. View

Kwon Y, Petrie K, Leibovitch B, Zeng L, Mezei M, Howell L . Selective Inhibition of SIN3 Corepressor with Avermectins as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer. Mol Cancer Ther. 2015; 14(8):1824-36. PMC: 4529816. DOI: 10.1158/1535-7163.MCT-14-0980-T. View

Li W, Zhang Z, Liu X, Cheng X, Zhang Y, Han X . The FOXN3-NEAT1-SIN3A repressor complex promotes progression of hormonally responsive breast cancer. J Clin Invest. 2017; 127(9):3421-3440. PMC: 5669564. DOI: 10.1172/JCI94233. View

Ramachandran S, Karp P, Jiang P, Ostedgaard L, Walz A, Fisher J . A microRNA network regulates expression and biosynthesis of wild-type and DeltaF508 mutant cystic fibrosis transmembrane conductance regulator. Proc Natl Acad Sci U S A. 2012; 109(33):13362-7. PMC: 3421220. DOI: 10.1073/pnas.1210906109. View

Dannenberg J, David G, Zhong S, van der Torre J, Wong W, DePinho R . mSin3A corepressor regulates diverse transcriptional networks governing normal and neoplastic growth and survival. Genes Dev. 2005; 19(13):1581-95. PMC: 1172064. DOI: 10.1101/gad.1286905. View

Farias E, Petrie K, Leibovitch B, Murtagh J, Chornet M, Schenk T . Interference with Sin3 function induces epigenetic reprogramming and differentiation in breast cancer cells. Proc Natl Acad Sci U S A. 2010; 107(26):11811-6. PMC: 2900697. DOI: 10.1073/pnas.1006737107. View

Orellana E, Kasinski A . No vehicle, no problem. Oncotarget. 2017; 8(57):96470-96471. PMC: 5722493. DOI: 10.18632/oncotarget.22100. View

Watanabe K, Yamamoto S, Sakaguti S, Isayama K, Oka M, Nagano H . A novel somatic mutation of SIN3A detected in breast cancer by whole-exome sequencing enhances cell proliferation through ERα expression. Sci Rep. 2018; 8(1):16000. PMC: 6207735. DOI: 10.1038/s41598-018-34290-1. View

10.

Cheng Y, Xiang G, Meng Y, Dong R . MiRNA-183-5p promotes cell proliferation and inhibits apoptosis in human breast cancer by targeting the PDCD4. Reprod Biol. 2016; 16(3):225-233. DOI: 10.1016/j.repbio.2016.07.002. View

11.

Li P, Sheng C, Huang L, Zhang H, Huang L, Cheng Z . MiR-183/-96/-182 cluster is up-regulated in most breast cancers and increases cell proliferation and migration. Breast Cancer Res. 2014; 16(6):473. PMC: 4303194. DOI: 10.1186/s13058-014-0473-z. View

12.

Song C, Zhang L, Wang J, Huang Z, Li X, Wu M . High expression of microRNA-183/182/96 cluster as a prognostic biomarker for breast cancer. Sci Rep. 2016; 6:24502. PMC: 4829912. DOI: 10.1038/srep24502. View

13.

David G, Grandinetti K, Finnerty P, Simpson N, Chu G, DePinho R . Specific requirement of the chromatin modifier mSin3B in cell cycle exit and cellular differentiation. Proc Natl Acad Sci U S A. 2008; 105(11):4168-72. PMC: 2393767. DOI: 10.1073/pnas.0710285105. View

14.

Agarwal V, Bell G, Nam J, Bartel D . Predicting effective microRNA target sites in mammalian mRNAs. Elife. 2015; 4. PMC: 4532895. DOI: 10.7554/eLife.05005. View

15.

Silverstein R, Ekwall K . Sin3: a flexible regulator of global gene expression and genome stability. Curr Genet. 2004; 47(1):1-17. DOI: 10.1007/s00294-004-0541-5. View

16.

Caswell-Jin J, Plevritis S, Tian L, Cadham C, Xu C, Stout N . Change in Survival in Metastatic Breast Cancer with Treatment Advances: Meta-Analysis and Systematic Review. JNCI Cancer Spectr. 2019; 2(4):pky062. PMC: 6305243. DOI: 10.1093/jncics/pky062. View

17.

Li Y, Zeng Q, Qiu J, Pang T, Ye F, Huang L . MiR-183-5p Promotes Proliferation, Metastasis and Angiogenesis in Breast Cancer Cells through Negatively Regulating Four and a Half LIM Protein 1. J Breast Cancer. 2020; 23(4):355-372. PMC: 7462817. DOI: 10.4048/jbc.2020.23.e47. View

18.

Lewis M, Liu J, Libby E, Lee M, Crawford N, Hurst D . SIN3A and SIN3B differentially regulate breast cancer metastasis. Oncotarget. 2016; 7(48):78713-78725. PMC: 5340233. DOI: 10.18632/oncotarget.12805. View

19.

Bansal N, Bosch A, Leibovitch B, Pereira L, Cubedo E, Yu J . Blocking the PAH2 domain of Sin3A inhibits tumorigenesis and confers retinoid sensitivity in triple negative breast cancer. Oncotarget. 2016; 7(28):43689-43702. PMC: 5190053. DOI: 10.18632/oncotarget.9905. View

20.

Ellison-Zelski S, Alarid E . Maximum growth and survival of estrogen receptor-alpha positive breast cancer cells requires the Sin3A transcriptional repressor. Mol Cancer. 2010; 9:263. PMC: 2956731. DOI: 10.1186/1476-4598-9-263. View